Sandra Horning, Jeff Rumens for Endpoints #JPM19
Roche vet Sandra Horning jumps on biopharma board no. 3 — what’s that worth?
Sandra Horning is in high demand.
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
